Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;159(3):1306-1307.
doi: 10.1016/j.chest.2020.09.267.

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019

Affiliations
Comment

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019

Claudio Tana et al. Chest. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Sweiss NJ, Korsten P, Baughman RP, Culver DA, Judson MA. Sweiss NJ, et al. Chest. 2021 Mar;159(3):1307-1308. doi: 10.1016/j.chest.2020.10.005. Chest. 2021. PMID: 33678263 Free PMC article. No abstract available.

Comment on

References

    1. Sweiss N.J., Korsten P., Syed H.J., et al. When the game changes: guidance to adjust sarcoidosis management during the coronavirus disease 2019 pandemic. Chest. 2020;158(3):892–895. - PMC - PubMed
    1. Singh J.A., Cameron C., Noorbaloochi S. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015;386(9990) 258-252. - PMC - PubMed
    1. RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19: preliminary report. N Engl J Med. 2020 NEJMoa2021436. - PMC - PubMed
    1. Zhao J., Cui W., Tian B.P. Efficacy of tocilizumab treatment in severely ill COVID-19 patients. Crit Care. 2020;24(1):524. - PMC - PubMed
    1. Salvarani C., Bajocchi G., Mancuso P., et al. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020;79(7):986–988. - PubMed